Cargando…
SLC6A14, an amino acid transporter, modifies the primary CF defect in fluid secretion
The severity of intestinal disease associated with Cystic Fibrosis (CF) is variable in the patient population and this variability is partially conferred by the influence of modifier genes. Genome-wide association studies have identified SLC6A14, an electrogenic amino acid transporter, as a genetic...
Autores principales: | Ahmadi, Saumel, Xia, Sunny, Wu, Yu-Sheng, Di Paola, Michelle, Kissoon, Randolph, Luk, Catherine, Lin, Fan, Du, Kai, Rommens, Johanna, Bear, Christine E |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
eLife Sciences Publications, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054531/ https://www.ncbi.nlm.nih.gov/pubmed/30004386 http://dx.doi.org/10.7554/eLife.37963 |
Ejemplares similares
-
SLC6A14 Is a Genetic Modifier of Cystic Fibrosis That Regulates Pseudomonas aeruginosa Attachment to Human Bronchial Epithelial Cells
por: Di Paola, Michelle, et al.
Publicado: (2017) -
Exploiting the metabolic dependencies of the broad amino acid transporter SLC6A14
por: Dejure, Francesca R., et al.
Publicado: (2020) -
492: CF innate immune defect affects CF intestinal microbiota
por: Scull, C., et al.
Publicado: (2021) -
Blockade of the amino acid transporter SLC6A14 suppresses tumor growth in colorectal Cancer
por: Lu, Ying, et al.
Publicado: (2022) -
Genetic polymorphisms and haplotypes of the organic cation transporter 1 gene (SLC22A1) in the Xhosa population of South Africa
por: Jacobs, Clifford, et al.
Publicado: (2014)